189
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Pharmacophore modeling coupled with scaffold hopping to identify novel and potent ribosomal S6 kinase (RSK2) protein antagonists as anti-cancer agents

, , &
Pages 4947-4955 | Received 27 Sep 2019, Accepted 31 Oct 2019, Published online: 12 Nov 2019

References

  • Aronchik, I., Appleton, B. A., Basham, S. E., Crawford, K., Del Rosario, M., Doyle, L. V., … Luu, C. A. (2014). Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancers. Molecular Cancer Research, 12(5), 803–812. doi:10.1158/1541-7786.MCR-13-0595
  • Bajaj, R., Sharma, V., & Kumar, V. (2014). Pharmacophore mapping: Prediction of BCR–ABL kinase inhibitory activity of α-benzylthio chalcones. Bulletin of Faculty of Pharmacy, Cairo University, 52(1), 103–108. doi:10.1016/j.bfopcu.2013.10.001
  • Boyer, S. J., Burke, J., Guo, X., Kirrane, T. M., Snow, R. J., Zhang, Y., … Westbrook, J. (2012). Indole RSK inhibitors. Part 1: Discovery and initial SAR. Bioorganic & medicinal chemistry Letters, 22, 733–737. doi:10.1016/j.bmcl.2011.10.030
  • Cho, Y.-Y. (2017). RSK2 and its binding partners in cell proliferation, transformation and cancer development. Archives of pharmacal Research, 40(3), 291–303. doi:10.1007/s12272-016-0880-z
  • Costales, A., Mathur, M., Ramurthy, S., Lan, J., Subramanian, S., Jain, R., … Appleton, B. A. (2014). 2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors. Bioorganic & medicinal chemistry Letters, 24, 1592–1596. doi:10.1016/j.bmcl.2014.01.058
  • Goldberg, D., Choi, Y., Cogan, D., Corson, M., DeLeon, R., Gao, A., … Kashem, M. (2008). Pyrazinoindolone inhibitors of MAPKAP-K2. Bioorganic & medicinal chemistry Letters, 18, 938–941. doi:10.1016/j.bmcl.2007.12.037
  • Jain, R., Mathur, M., Lan, J., Costales, A., Atallah, G., Ramurthy, S., … Warne, B. (2015). Discovery of potent and selective RSK inhibitors as biological probes. Journal of medicinal Chemistry, 58(17), 6766–6783. doi:10.1021/acs.jmedchem.5b00450
  • Keränen, H., Pérez-Benito, L., Ciordia, M., Delgado, F., Steinbrecher, T. B., Oehlrich, D., … Tresadern, G. (2017). Acylguanidine beta secretase 1 inhibitors: A combined experimental and free energy perturbation study. Journal of chemical theory and Computation, 13(3), 1439–1453. doi:10.1021/acs.jctc.6b01141
  • Leimkuhler, B. J., & Sweet, C. R. (2004). The canonical ensemble via symplectic integrators using Nosé and Nosé–Poincaré chains. The Journal of chemical Physics, 121(1), 108–116. doi:10.1063/1.1740753
  • Ludwik, K. A., Campbell, J. P., Li, M., Li, Y., Sandusky, Z. M., Pasic, L., … O'Doherty, G. A. (2016). Development of a RSK inhibitor as a novel therapy for triple-negative breast cancer. Molecular cancer Therapeutics, 15(11), 2598–2608. doi:10.1158/1535-7163.MCT-16-0106
  • Miller, R. M., Paavilainen, V. O., Krishnan, S., Serafimova, I. M., & Taunton, J. (2013). Electrophilic fragment-based design of reversible covalent kinase inhibitors. Journal of the American Chemical Society, 135(14), 5298–5301. doi:10.1021/ja401221b
  • Natarajan, P., Priyadarshini, V., Pradhan, D., Manne, M., Swargam, S., Kanipakam, H., … Amineni, U. (2016). E-pharmacophore-based virtual screening to identify GSK-3β inhibitors. Journal of Receptors and Signal Transduction, 36(5), 445–458. doi:10.3109/10799893.2015.1122043
  • Natarajan, P., Munikumar, M., Swargam, S., Hema, K., Sudheer Kumar, K., & Umamaheswari, A. (2015). 197 Combination of e-pharmacophore modeling, multiple docking strategies and molecular dynamic simulations to discover of novel antagonists of BACE1. Journal of Biomolecular Structure and Dynamics, 33, 129–130. doi:10.1080/07391102.2015.1032834
  • Valiev, M., Yang, J., Adams, J. A., Taylor, S. S., & Weare, J. H. (2007). Phosphorylation reaction in cAPK protein kinase-free energy quantum mechanical/molecular mechanics simulations. The Journal of Physical Chemistry B, 111(47), 13455–13464. doi:10.1021/jp074853q
  • Vilar, S., Karpiak, J., Berk, B., & Costanzi, S. (2011). In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor. Journal of Molecular Graphics and Modelling, 29(6), 809–817. doi:10.1016/j.jmgm.2011.01.005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.